Juan Pablo Arab

1 month ago | hcplive.com | Jeff McIntyre |Mazen Noureddin |Juan Pablo Arab

On March 14, 2024, the US Food and Drug Administration (FDA) made history when it granted accelerated approval to Madrigal Pharmaceuticals’ resmetirom (Rezdiffra), making it the first and only treatment for noncirrhotic nonalcoholic steatohepatitis (NASH), now known as metabolic dysfunction-associated steatohepatitis (MASH). One year later, resmetirom’s impact on clinical practice and patient care continues to evolve.

1 month ago | hcplive.com | Jeff McIntyre |Mazen Noureddin |Juan Pablo Arab

On March 14, 2024, the US Food and Drug Administration (FDA) made history when it granted accelerated approval to Madrigal Pharmaceuticals’ resmetirom (Rezdiffra), making it the first and only treatment for noncirrhotic nonalcoholic steatohepatitis (NASH), now known as metabolic dysfunction-associated steatohepatitis (MASH). One year later, resmetirom’s impact on clinical practice and patient care continues to evolve.

Jan 23, 2025 | thelancet.com | Juan Pablo Arab |Departamento de Gastroenterología |Escuela de Medicina

Acute liver failure - The Lancet

Oct 2, 2024 | nature.com | Juan Pablo Arab |Vincent Wong

To coincide with the 20th anniversary of Nature Reviews Gastroenterology & Hepatology, we asked three experts to reflect on the past, present and future of metabolic dysfunction-associated steatotic liver disease (MASLD) research and clinical management. They comment on how MASLD research and clinical management has changed over the past 20 years, the strengths and limitations of the MASLD field today, and their predictions for progress over the next 20 years.

Aug 1, 2024 | thelancet.com | Juan Pablo Arab |Departamento de Gastroenterología |Escuela de Medicina

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.